Fulcrum Therapeutics
FULC
FULC
126 hedge funds and large institutions have $570M invested in Fulcrum Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
25% more funds holding
Funds holding: 101 → 126 (+25)
14% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 29
3.3% less ownership
Funds ownership: 100.78% → 97.48% (-3.3%)
Holders
126
Holding in Top 10
3
Calls
$30.4M
Puts
$1.21M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$4.53M | |
| 3 | +$4.34M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$4.02M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.76M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$12.1M | |
| 3 | -$8.1M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.81M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.78M |